Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial - Carrier, Serge; Brock, Gerald B; Pommerville, Peter J; Shin, Janey; Anglin, Greg; Whitaker, Steven; Beasley, Jr, Charles M (Journal of sexual medicine, 2005)
Keywords: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Adult; Aged; Canada; Carbolines - administration & dosage; Carbolines - adverse effects; Carbolines - therapeutic use; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction - drug therapy; Erectile Dysfunction - etiology; Erectile Dysfunction - physiopathology; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases - metabolism; Severity of Illness Index; Tadalafil; Treatment Outcome; Vasodilator Agents - administration & dosage; Vasodilator Agents - adverse effects; Vasodilator Agents - therapeutic use; Canada